Innova Captab Q3 FY25 Results & Concall Highlights: Revenue, Margins & Order Book
Published 26 Aug 2026 | Pharmaceuticals & Biotechnology | Market Cap: ₹6.2K Cr
Innova Captab expects continued growth driven by existing volume growth and the new Jammu facility. The Jammu facility, operational from January 14, 2025, is expected to drive significant incremental revenue growth, targeting ₹400 to ₹500 crores in FY '26 and aiming for ₹1,000 crores in 2-3 years.
From Innova Captab's Q3 FY25 earnings-call transcript · updated 26 Aug 2026.
Price
₹1,040
Market Cap
₹6.2K Cr
P/E Ratio
40.4
How does Innova Captab rank in Pharmaceuticals & Biotechnology?
Compare Innova Captab against every Pharmaceuticals & Biotechnology company this quarter on revenue, margins and earnings-call signals.
Innova Captab — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹448 Cr, net profit ₹38 Cr.
Full financials →📊 Revenue & Sales Performance
- →Innova Captab expects continued growth driven by existing volume growth and the new Jammu facility.
- →Jammu facility revenue is estimated between ₹400-₹500 crores in FY '26, with potential to reach ₹1,000 crores in 2-3 years.
- →Peak utilization for Jammu plant expected around 70-75%, with potential peak revenue near ₹1,500-₹2,000 crores.
- →Overall company growth, including Jammu, is anticipated at 25%+ for FY '26.
- →CDMO business has shown a strong CAGR of 20%+, expected to sustain early teens growth despite pricing pressure.
- →Domestic and international generic businesses continue to expand, with international growing 17% YoY.
- →Sharon Bio-Medicines forecasted to grow in early teens over the coming years.
- →Pricing for APIs stable Q-on-Q but slightly declined YoY; future pricing expected to stabilize.
- →The company is confident of sustaining growth beyond FY '25.
📈 Profitability & Margins
- →The Jammu facility, operational from January 14, 2025, is expected to drive significant incremental revenue growth, targeting ₹400 to ₹500 crores in FY '26 and aiming for ₹1,000 crores in 2-3 years.
- →Margins from Jammu are expected to align with existing business margins of 15-16%, with potential for slight improvement over time.
- →Peak utilization at Jammu is expected around 70-75%, enabling revenue potential of up to ₹1,500 to ₹1,600 crores at maturity.
- →Overall EBITDA margins may improve modestly by 100-200 basis points in the medium-term as Jammu stabilizes and benefits from GST incentives.
- →CDMO business growth is expected in the early teens percentage range, despite some year-on-year pricing pressure.
- →The company remains confident in continued volume growth and stabilization of prices, supporting sustained profitability and EPS growth over coming years.
🏗️ Capital Expenditure Plans
- →Innova Captab has recently commercialized its Jammu facility in January 2025, representing a significant capital investment.
- →The Jammu facility is expected to generate incremental revenue of ₹400-500 crores in FY26, ramping up further to peak utilization by FY28.
- →The company is focused on expanding capacity and product portfolio through this new facility, with an estimated peak revenue potential of around ₹2,000 crores at full utilization.
- →The Jammu facility is compliant with stringent future-ready regulations, designed with a 40-50 year vision.
- →Innova Captab is eligible for Central Government incentives including a GST-linked incentive of 300% of investment in eligible plant and machinery for up to 10 years and a capital interest subvention reducing interest cost by ~600 basis points.
- →There is an ongoing focus on ramping up Jammu's capacity and mitigating any ramp-up related EBITDA headwinds.
💰 Fundraising & Capital Structure
- →The transcript does not explicitly mention any current or planned fundraising through debt or equity.
- →However, the company is set to benefit from government incentive schemes, including a GST-linked incentive and a capital interest subvention on loans, which will reduce interest costs by approximately 600 basis points.
- →There is discussion of investments in new facilities, such as the Jammu plant, designed to last 40-50 years, but no direct mention of new fundraising activities.
- →Management refrained from giving consolidated revenue guidance, indicating a cautious outlook without highlighting specific capital-raising plans.
- →Overall, there is no clear indication of imminent debt or equity fundraising in the provided content.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Innova Captab Q3 FY25 results?
Innova Captab expects continued growth driven by existing volume growth and the new Jammu facility. The Jammu facility, operational from January 14, 2025, is expected to drive significant incremental revenue growth, targeting ₹400 to ₹500 crores in FY '26 and aiming for ₹1,000 crores in 2-3 years.
What is Innova Captab share price analysis?
Innova Captab currently shows a neutral. The stock trades at a P/E of 40.4 with a market cap of ₹6,229 Cr. Investors should review the full earnings analysis for detailed insights.
Is Innova Captab planning capital expenditure?
Innova Captab has recently commercialized its Jammu facility in January 2025, representing a significant capital investment.
Keep Innova Captab on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.